Greenwich Lifesciences Stock Forecast - Naive Prediction

GLSI Stock  USD 25.47  1.91  8.11%   
The Naive Prediction forecasted value of Greenwich Lifesciences on the next trading day is expected to be 20.83 with a mean absolute deviation of 1.06 and the sum of the absolute errors of 64.96. Greenwich Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Greenwich Lifesciences' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 25th of January 2026 the rsi of Greenwich Lifesciences' share price is below 20 . This usually indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Greenwich Lifesciences' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Greenwich Lifesciences, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Greenwich Lifesciences' stock price prediction:
EPS Estimate Next Quarter
(0.34)
EPS Estimate Current Year
(1.23)
EPS Estimate Next Year
(1.36)
Wall Street Target Price
47.5
EPS Estimate Current Quarter
(0.36)
Using Greenwich Lifesciences hype-based prediction, you can estimate the value of Greenwich Lifesciences from the perspective of Greenwich Lifesciences response to recently generated media hype and the effects of current headlines on its competitors.

Greenwich Lifesciences Hype to Price Pattern

Investor biases related to Greenwich Lifesciences' public news can be used to forecast risks associated with an investment in Greenwich. The trend in average sentiment can be used to explain how an investor holding Greenwich can time the market purely based on public headlines and social activities around Greenwich Lifesciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
The Naive Prediction forecasted value of Greenwich Lifesciences on the next trading day is expected to be 20.83 with a mean absolute deviation of 1.06 and the sum of the absolute errors of 64.96.

Greenwich Lifesciences after-hype prediction price

    
  USD 32.0  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Greenwich Lifesciences to cross-verify your projections.
For more detail on how to invest in Greenwich Stock please use our How to Invest in Greenwich Lifesciences guide.

Greenwich Lifesciences Additional Predictive Modules

Most predictive techniques to examine Greenwich price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Greenwich using various technical indicators. When you analyze Greenwich charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Greenwich Lifesciences Cash Forecast

Predicting cash flow or other financial metrics requires analysts to utilize a variety of statistical methods, techniques, and algorithms. These tools help uncover hidden patterns in the Greenwich Lifesciences' financial statements, enabling forecasts of their impact on future stock prices.
 
Cash  
First Reported
2018-12-31
Previous Quarter
3.1 M
Current Value
3.8 M
Quarterly Volatility
10.4 M
 
Covid
A naive forecasting model for Greenwich Lifesciences is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Greenwich Lifesciences value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Greenwich Lifesciences Naive Prediction Price Forecast For the 26th of January

Given 90 days horizon, the Naive Prediction forecasted value of Greenwich Lifesciences on the next trading day is expected to be 20.83 with a mean absolute deviation of 1.06, mean absolute percentage error of 2.64, and the sum of the absolute errors of 64.96.
Please note that although there have been many attempts to predict Greenwich Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Greenwich Lifesciences' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Greenwich Lifesciences Stock Forecast Pattern

Backtest Greenwich LifesciencesGreenwich Lifesciences Price PredictionBuy or Sell Advice 

Greenwich Lifesciences Forecasted Value

In the context of forecasting Greenwich Lifesciences' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Greenwich Lifesciences' downside and upside margins for the forecasting period are 13.30 and 28.36, respectively. We have considered Greenwich Lifesciences' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
25.47
20.83
Expected Value
28.36
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Greenwich Lifesciences stock data series using in forecasting. Note that when a statistical model is used to represent Greenwich Lifesciences stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria119.0796
BiasArithmetic mean of the errors None
MADMean absolute deviation1.0649
MAPEMean absolute percentage error0.0638
SAESum of the absolute errors64.9599
This model is not at all useful as a medium-long range forecasting tool of Greenwich Lifesciences. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Greenwich Lifesciences. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Greenwich Lifesciences

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Greenwich Lifesciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Greenwich Lifesciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
24.4732.0039.53
Details
Intrinsic
Valuation
LowRealHigh
22.9930.5238.05
Details
Bollinger
Band Projection (param)
LowMiddleHigh
4.6818.2631.84
Details
1 Analysts
Consensus
LowTargetHigh
43.2347.5052.73
Details

Greenwich Lifesciences After-Hype Price Prediction Density Analysis

As far as predicting the price of Greenwich Lifesciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Greenwich Lifesciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Greenwich Lifesciences, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Greenwich Lifesciences Estimiated After-Hype Price Volatility

In the context of predicting Greenwich Lifesciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Greenwich Lifesciences' historical news coverage. Greenwich Lifesciences' after-hype downside and upside margins for the prediction period are 24.47 and 39.53, respectively. We have considered Greenwich Lifesciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
25.47
32.00
After-hype Price
39.53
Upside
Greenwich Lifesciences is not too volatile at this time. Analysis and calculation of next after-hype price of Greenwich Lifesciences is based on 3 months time horizon.

Greenwich Lifesciences Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Greenwich Lifesciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Greenwich Lifesciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Greenwich Lifesciences, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  1.82 
7.53
  6.53 
  0.31 
9 Events / Month
7 Events / Month
In about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
25.47
32.00
25.64 
209.75  
Notes

Greenwich Lifesciences Hype Timeline

Greenwich Lifesciences is currently traded for 25.47. The entity has historical hype elasticity of 6.53, and average elasticity to hype of competition of -0.31. Greenwich is projected to increase in value after the next headline, with the price projected to jump to 32.0 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 25.64%, whereas the daily expected return is currently at 1.82%. The volatility of related hype on Greenwich Lifesciences is about 4403.51%, with the expected price after the next announcement by competition of 25.16. Greenwich Lifesciences currently holds 1.56 M in liabilities. Greenwich Lifesciences has a current ratio of 64.43, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Greenwich Lifesciences' use of debt, we should always consider it together with its cash and equity.Given the investment horizon of 90 days the next projected press release will be in about 9 days.
Check out Historical Fundamental Analysis of Greenwich Lifesciences to cross-verify your projections.
For more detail on how to invest in Greenwich Stock please use our How to Invest in Greenwich Lifesciences guide.

Greenwich Lifesciences Related Hype Analysis

Having access to credible news sources related to Greenwich Lifesciences' direct competition is more important than ever and may enhance your ability to predict Greenwich Lifesciences' future price movements. Getting to know how Greenwich Lifesciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Greenwich Lifesciences may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
CGTXCognition Therapeutics(0.14)10 per month 0.00 (0.07) 8.89 (8.38) 24.96 
ATOSAtossa Genetics 0.02 11 per month 0.00 (0.17) 6.45 (6.25) 20.34 
TVGNTevogen Bio Holdings 0.03 9 per month 0.00 (0.16) 10.00 (8.89) 26.81 
ONCYOncolytics Biotech(0.02)8 per month 4.18  0.04  8.55 (7.07) 20.66 
SRZNSurrozen(1.45)11 per month 4.12  0.11  12.23 (6.75) 34.29 
HURATuHURA Biosciences(0.05)12 per month 0.00 (0.25) 7.73 (10.53) 50.34 
SEERSeer Inc 0.01 8 per month 0.00 (0.14) 3.41 (3.06) 9.98 
IRDOpus Genetics(0.07)10 per month 3.57  0.09  6.70 (6.10) 26.50 
AGENAgenus Inc 0.01 9 per month 0.00 (0.1) 6.63 (6.05) 30.06 
IMMXImmix Biopharma(0.05)7 per month 4.35  0.15  15.04 (8.41) 28.79 

Other Forecasting Options for Greenwich Lifesciences

For every potential investor in Greenwich, whether a beginner or expert, Greenwich Lifesciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Greenwich Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Greenwich. Basic forecasting techniques help filter out the noise by identifying Greenwich Lifesciences' price trends.

Greenwich Lifesciences Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Greenwich Lifesciences stock to make a market-neutral strategy. Peer analysis of Greenwich Lifesciences could also be used in its relative valuation, which is a method of valuing Greenwich Lifesciences by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Greenwich Lifesciences Market Strength Events

Market strength indicators help investors to evaluate how Greenwich Lifesciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Greenwich Lifesciences shares will generate the highest return on investment. By undertsting and applying Greenwich Lifesciences stock market strength indicators, traders can identify Greenwich Lifesciences entry and exit signals to maximize returns.

Greenwich Lifesciences Risk Indicators

The analysis of Greenwich Lifesciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Greenwich Lifesciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting greenwich stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Greenwich Lifesciences

The number of cover stories for Greenwich Lifesciences depends on current market conditions and Greenwich Lifesciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Greenwich Lifesciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Greenwich Lifesciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Greenwich Lifesciences Short Properties

Greenwich Lifesciences' future price predictability will typically decrease when Greenwich Lifesciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Greenwich Lifesciences often depends not only on the future outlook of the potential Greenwich Lifesciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Greenwich Lifesciences' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding13 M
Cash And Short Term Investments4.1 M
When determining whether Greenwich Lifesciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Greenwich Lifesciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Greenwich Lifesciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Greenwich Lifesciences Stock:
Check out Historical Fundamental Analysis of Greenwich Lifesciences to cross-verify your projections.
For more detail on how to invest in Greenwich Stock please use our How to Invest in Greenwich Lifesciences guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Greenwich Lifesciences. If investors know Greenwich will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Greenwich Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.46)
Return On Assets
(2.54)
Return On Equity
(5.43)
The market value of Greenwich Lifesciences is measured differently than its book value, which is the value of Greenwich that is recorded on the company's balance sheet. Investors also form their own opinion of Greenwich Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Greenwich Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Greenwich Lifesciences' market value can be influenced by many factors that don't directly affect Greenwich Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Greenwich Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Greenwich Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Greenwich Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.